AGP Executive Report
Last update: 10 hours agoDEA/Rescheduling Watch: Nebraska, Indiana and Louisiana AGs sued to block Trump’s marijuana reclassification, arguing the administration skipped normal rulemaking and may clash with a 1967 narcotics treaty. Federal Medical Cannabis Access: Medx Holdings says it has filed for DEA registration for state-licensed medical cannabis operations under the new Schedule III framework. Market Moves: Curaleaf announced a one-for-three reverse split tied to potential NYSE/NASDAQ uplisting requirements, while SAM’s Medicare hemp coverage challenge was dismissed by a federal judge. Enforcement (Online Drug Shipments): Bulgaria seized 1,000+ narcotics parcels ordered online, including cannabis vapes, refills and edibles—targeting teen-focused products. Africa Drug War: Nigeria’s NDLEA says it shut down a major meth lab and arrested cartel members, underscoring ongoing pressure on organized drug networks. CBD/Global Policy Signals: A Swiss study claims cannabis may raise testosterone in young men, while EU talks are set to consider new restrictions on Chinese imports amid “China Shock 2.0” concerns. Cannabis Culture/Branding: Garcia Hand Picked is returning to California dispensaries starting June 5, leaning into sun-grown craft positioning.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
